GeneralConnection.com ➔ Dictionary
Dictionary Search

tardive

Synonyms

Adjective

1. late

Usage
Spotlight on the Psychosocial Impact of Tardive Dyskinesia - Psychiatry Advisor
Masking and Unmasking in Tardive Dyskinesia - Pharmacy Practice News
Tardive Dyskinesia in Older Adults: Identification and Management in Long-Term Care Settings - Psychiatric Times
Clinical practice guidelines for the treatment of tardive dyskinesia in Europe: A descriptive review - Cambridge University Press & Assessment
Detecting Tardive Dyskinesia Using Video-Based Artificial Intelligence - Psychiatrist.com
Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea - NeurologyLive
This condition affects at least 5% of people who take antipsychotic medication - Health: Trusted and Empathetic Health and Wellness Information
Distinguishing Tardive Dyskinesia From Other Movement Disorders - HMP Global Learning Network
5 Rules to Better Tardive Dyskinesia Management - HealthCentral
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia - PR Newswire
Washington Wants Iran’s Kurds In The Fight—Why Is The Opposition Against Them? - Forbes
EMA Says Active Substance in Tardive Dyskinesia Drug Not New - Medscape
Real-world data shows AUSTEDO improves life for patients with tardive dyskinesia - PharmaTimes
Building a Tardive Dyskinesia Center of Excellence: A Multidisciplinary Model - Pharmacy Practice News
Valbenazine Linked to Better Physical and Emotional Well-Being in Tardive Dyskinesia - NeurologyLive
New Review on VMAT2 Inhibitors and Ingrezza for Treatment of Tardive Dyskinesia - Psychiatric Times
Managing Tardive Dyskinesia (Part 2) - Pharmacy Practice News
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia - NeurologyLive
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia Severity - Psychiatric Times
Patient Awareness of Tardive Dyskinesia: Insights From Cherian Karunapuzha, MD - Psychiatric Times
Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders - Pharmacy Practice News
Risk Factors of Tardive Dyskinesia - Pharmacy Times
Well-Rounded Examination for Treatment of Tardive Dyskinesia - Psychiatric Times
Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden - PR Newswire
Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive - Fierce Pharma
Tardive Dyskinesia: Spotlight on Current Approaches to Treatment - Psychiatry Online
New Post-Hoc Analysis: Treatment With Ingrezza Results in Earlier Remission of Tardive Dyskinesia Symptoms and Reduced Disease Burden - Psychiatric Times
AI Tool Shows Promise for Improving Early Detection of Tardive Dyskinesia - Physician's Weekly
Accurate Diagnosis of Tardive Dyskinesia Is Critical to Optimal Outcomes - Pharmacy Practice News
Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics - MedPage Today
How to Talk About Tardive Dyskinesia with A Doctor - Healthgrades Health Library
Risperdal (Risperidone) Side Effects: Common and Rare - Verywell Mind
Tardive Dyskinesia's Impact on Quality of Life - MedPage Today
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice - Pharmacy Times
What’s New in Tardive Dyskinesia, With Jonathan Meyer, MD - HCPLive
Phase 2 Study Initiated for NBI-1065890 to Treat Tardive Dyskinesia - Psychiatric Times
Most Tardive Dyskinesia Cases Go Undiagnosed, Real-World Study Finds - Pharmacy Practice News
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia - HMP Global Learning Network
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis - Yahoo Finance
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms - Psychiatric Times
Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score - Psychiatric Times
How VMAT2 Inhibitors Are Reshaping Tardive Dyskinesia Care - Pharmacy Practice News
Assessing Tardive Dyskinesia: AIMS and the Clinician’s Tardive Inventory - Pharmacy Practice News
Diagnostic Challenges in Distinguishing Huntington Disease From Tardive Dyskinesia - Psychiatrist.com
Tardive Dyskinesia Management Gaps in LongTerm Care - Pharmacy Practice News
Sustained Benefits of Long-Term VMAT2 Inhibitor Therapy in Tardive Dyskinesia - Pharmacy Times
Monitoring for Tardive Dyskinesia: Who Is at Greatest Risk? - Physician's Weekly
A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation - Nature
Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: A case report - Wiley Online Library
Digital Tools to Detect Tardive Dyskinesia - MedPage Today
Neurocrine Biosciences Announces New Survey Revealing Need for Routine Screening and Earlier Diagnosis for People Living with Tardive Dyskinesia - PR Newswire
Neurocrine’s Next VMAT2 Study Adds Depth To Tardive Dyskinesia Story - Yahoo Finance
Caregiving Guide for Helping to Manage Tardive Dyskinesia - HealthCentral
Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO™ Study Demonstrating INGREZZA® (valbenazine) Capsules Improved Functionality and Quality of Life in Patients with Tardive Dyskinesia - PR Newswire
Assessing Neurocrine Biosciences (NBIX) Valuation After New Phase 2 VMAT2 Tardive Dyskinesia Trial Launch - Yahoo Finance
Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia - PR Newswire
9 Questions to Ask Your Doctor About Taking VMAT2 Inhibitors for TD - HealthCentral
Neurocrine Biosciences and Carnie Wilson Team Up to Launch ConnectING with Carnie™ Awareness Campaign for People with Tardive Dyskinesia - PR Newswire
Deep Brain Stimulation for Tardive Dyskinesia - MedPage Today
Neurocrine Biosciences Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia - PR Newswire
The Role of Ultrasound in Diagnosing Tardive Dyskinesia: A New Frontier in Movement Disorders - Physician's Weekly
Rapid-onset tardive dyskinesia–like disorder after a single dose of haloperidol - CMAJ
Supplements for Tardive Dyskinesia - Healthgrades Health Library
Understanding the Impact of Tardive Dyskinesia Across Patient Populations - Pharmacy Times
A Choice and a Voice: Supporting Patient-Centered Decisions in Tardive Dyskinesia Care - Medscape
Neurocrine holds on to branded tardive dyskinesia push with help from Wilson Phillips star - Fierce Pharma
ICD-Confirmed Tardive Dyskinesia Diagnosis Seen in Only 5% of Suspected Cases - Physician's Weekly
Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry - PR Newswire
Teva Pharmaceuticals Reports Positive Real-World Data on AUSTEDO and AUSTEDO XR for Tardive Dyskinesia Treatment in IMPACT-TD Registry - Quiver Quantitative
Patient Perspectives on Barriers to Diagnosis and Treatment of Tardive Dyskinesia from a Cross-sectional Survey (P4-5.018) - Neurology® Journals
Valbenazine Safe and Effective for Long-Term Treatment of Tardive Dyskinesia in Elders - NeurologyLive
Neurocrine’s New Tardive Dyskinesia Trial And What It Means For Valuation - Sahm
Working with Tardive Dyskinesia: Requesting Accommodations - Healthline
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR - PR Newswire
Which Treatment for Tardive Dyskinesia Is Right for You? - HealthCentral
Valbenazine Improves Tardive Dyskinesia in Older Adults Over Long Term | Psychiatric News - Psychiatry Online
Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA® (valbenazine) Capsules - PR Newswire
Your Questions, Answered, on Tardive Dyskinesia - HealthCentral
Why Singer Carnie Wilson Is Raising Awareness Of Tardive Dyskinesia - Forbes
Improvements Over Time with Valbenazine in Elderly Adults (≥65 Years) with Tardive Dyskinesia: Post Hoc Analyses of 2 Long-Term Studies - Psychiatrist.com
Neurocrine Biosciences Presents Real-World Data on Therapeutic Dose Attainment and Dosing Trends of VMAT2 Inhibitors in Patients With Tardive Dyskinesia - PR Newswire
Neurocrine Biosciences Presents 48-Week Remission Data on Treatment of Tardive Dyskinesia With INGREZZA® (valbenazine) Capsules - PR Newswire
Antipsychotics and Tardive Dyskinesia: What’s the Connection? - HealthCentral
Pro Football Hall of Famer Terrell Davis, Teva call attention to ‘The Other TD’ - Medical Marketing and Media
How to Improve the Symptoms of Tardive Dyskinesia - HealthCentral
Teva Taps Terrell (TD) Davis To Combat 'The Other TD' (Tardive Dyskinesia) 11/11/2025 - MediaPost
Neurocrine initiates phase 2 study for tardive dyskinesia treatment - Investing.com
Tardive Dyskinesia Treatment Market Size, Share | CAGR Of 6.3% - Market.us
Awareness of Multiple Treatment Options for Tardive Dyskinesia: Tips from Dr Jonathan Meyer - Psychiatric Times
Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg Capsules - PR Newswire
Haloperidol Induced Orofacial Dyskinesia: Clinical Insights Into Buccolingual Masticatory Syndrome - Wiley Online Library
New Ingrezza Data Demonstrates Functional and Quality of Life Improvements in Patients With Tardive Dyskinesia - Psychiatric Times
Neurocrine leans on singer Carnie Wilson for tardive dyskinesia push - Medical Marketing and Media
Neurocrine leans on singer Carnie Wilson for tardive dyskinesia push - PRWeek
Teva Pharmaceutical Industries Shares Positive Patient Survey Results for AUSTEDO XR® in Tardive Dyskinesia Treatment - Quiver Quantitative
Tardive Dyskinesia: Etiology, Prevention, and Management - Psychiatrist.com
6 Ways to Get Involved for Tardive Dyskinesia (TD) Awareness Week - Healthline
Latest Treatments for Tardive Dyskinesia - HealthCentral
What You Need to Know About VMAT2 Inhibitors for Tardive Dyskinesia - HealthCentral
Selecting a Treatment Option for Tardive Dyskinesia - Physician's Weekly
Foreign Language Equivalents
Foreign Language Equivalents of 'tardive'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
tardiev,   tardove,   tardivee,   atrdive,   tadive,   tardivw,   tarive,   tardivr,   rardive,   ttardive,   tardvie,   trdive,   yardive,   taridve,   tardibe,   taardive,   ardive,   tarsive,   tardve,   tardiive,   tardie,   taedive,   tardiv,   tarrdive,   tradive,   tatdive,   tsrdive,   tarddive,   tardivve,   tardice,   tarfive,   tarduve,   tadrive
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z